Targeting the cancer initiating cell: the Achilles' heel of cancer.
McCubrey
James A
JA
Department of Microbiology & Immunology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA. mccubreyj@ecu.edu
Chappell
William H
WH
Abrams
Stephen L
SL
Franklin
Richard A
RA
Long
Jacquelyn M
JM
Sattler
Jennifer A
JA
Kempf
C Ruth
CR
Laidler
Piotr
P
Steelman
Linda S
LS
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use; D045744:Cell Line, Tumor; D002471:Cell Transformation, Neoplastic; D019587:Dietary Supplements; D019008:Drug Resistance, Neoplasm; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000473:pathology* / Q000503:physiopathology* / Q000628:therapy; D014411:Neoplastic Stem Cells / Q000473:pathology / Q000502:physiology*; D011471:Prostatic Neoplasms / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D015398:Signal Transduction / Q000502:physiology
D000970:Antineoplastic Agents; D001688:Biological Products